Trial intelligence / Profile preview

Platelet-rich fibrin for temporomandibular joint osteoarthritis

RBR-9rdw98sPhase 2Recruiting

Sponsor
Faculdade de Medicina de Petrópolis
Start
Jan 2025
Countries
1
01

Overview

Phase 2, randomised, single-blind trial in Temporomandibular Osteoarthritis comparing Autologous platelet-rich fibrin, Autologous platelet-rich fibrin + hyaluronic acid and Hyaluronic acid (3 arms). Started Jan 2025; status: recruiting.

02

Drugs

platelet rich fibrinhyaluronic acid
03

Conditions

Temporomandibular Osteoarthritis

Beyond the preview

Go deeper on RBR-9rdw98s.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-9rdw98s.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call